CFTR and cystic fibrosis: Future research, should prioritize validation of the sputum markers established by our workflow in larger, longitudinal cohorts and could enable the development of personalized interventions, enhanced subclassification of COPD as well as infection and inflammation in the CF patients that can be treated at the underlying protein defect with CFTR modulators11,68,69.